1Life Healthcare Stock Forecast, Price & News

1Life Healthcare's stock was trading at $24.30 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ONEM shares have increased by 38.4% and is now trading at $33.63.
View which stocks have been most impacted by COVID-19.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 1Life Healthcare in the last year. There are currently 4 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for 1Life Healthcare or view MarketBeat's top 5 stock picks.

Wall Street analysts have given 1Life Healthcare a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but 1Life Healthcare wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

1Life Healthcare is scheduled to release its next quarterly earnings announcement on Wednesday, March 17th 2021.
View our earnings forecast for 1Life Healthcare.

1Life Healthcare, Inc. (NASDAQ:ONEM) issued its quarterly earnings data on Sunday, November, 15th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.19) by $0.06. The firm had revenue of $101.67 million for the quarter, compared to the consensus estimate of $86.16 million. The firm's quarterly revenue was up 46.0% compared to the same quarter last year. During the same period last year, the firm posted ($0.82) earnings per share.
View 1Life Healthcare's earnings history.

1Life Healthcare updated its fourth quarter 2020 After-Hours earnings guidance on Tuesday, November, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $104-109 million, compared to the consensus revenue estimate of $90.9 million.

12 brokers have issued 1 year price objectives for 1Life Healthcare's shares. Their forecasts range from $24.00 to $44.00. On average, they anticipate 1Life Healthcare's stock price to reach $37.08 in the next twelve months. This suggests a possible upside of 10.2% from the stock's current price.
View analysts' price targets for 1Life Healthcare.

Some companies that are related to 1Life Healthcare include Hologic (HOLX), Exact Sciences (EXAS), The Cooper Companies (COO), Teleflex (TFX), MERCK Kommanditgesellschaft auf Aktien (MRK.F) (MRK), Smith & Nephew (SNN), Quest Diagnostics (DGX), Insulet (PODD), STERIS (STE), bioMérieux (BMXMF), Sonova (SONVY), Varian Medical Systems (VAR), Cardinal Health (CAH), (BIO.B) (BIO.B) and Bio-Rad Laboratories (BIO).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other 1Life Healthcare investors own include Teladoc Health (TDOC), Advanced Micro Devices (AMD), Fastly (FSLY), Etsy (ETSY), Livongo Health (LVGO), NVIDIA (NVDA), The Boeing (BA), Alibaba Group (BABA), The Walt Disney (DIS) and DocuSign (DOCU).

(ONEM) raised $262 million in an initial public offering (IPO) on Friday, January 31st 2020. The company issued 17,500,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Allen & Company LLC, Citigroup, Piper Jaffray, Wells Fargo Securities, William Blair, Baird and SunTrust Robinson Humphrey were co-managers.

1Life Healthcare trades on the NASDAQ under the ticker symbol "ONEM."

1Life Healthcare's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (4.76%), 12 West Capital Management LP (1.05%), State Street Corp (1.10%), Summit Partners Public Asset Management LLC (0.91%), Morgan Stanley (0.51%) and Charles Schwab Investment Management Inc. (0.50%). Company insiders that own 1Life Healthcare stock include Amir Dan Rubin, Andrew S Diamond, David P Kennedy, Kimber D Lockhart and Lisa A Mango.
View institutional ownership trends for 1Life Healthcare.

ONEM stock was sold by a variety of institutional investors in the last quarter, including Blair William & Co. IL, Jackson Square Partners LLC, LPL Financial LLC, Janney Montgomery Scott LLC, Victory Capital Management Inc., and Foundry Partners LLC. Company insiders that have sold 1Life Healthcare company stock in the last year include Amir Dan Rubin, Andrew S Diamond, David P Kennedy, Kimber D Lockhart, and Lisa A Mango.
View insider buying and selling activity for 1Life Healthcare.

ONEM stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., 12 West Capital Management LP, State Street Corp, Summit Partners Public Asset Management LLC, Morgan Stanley, Charles Schwab Investment Management Inc., HarbourVest Partners LLC, and Clough Capital Partners L P.
View insider buying and selling activity for 1Life Healthcare.

Shares of ONEM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ONEM stock can currently be purchased for approximately $33.63.

1Life Healthcare has a market capitalization of $4.47 billion and generates $276.26 million in revenue each year. The company earns $-52,550,000.00 in net income (profit) each year or ($2.84) on an earnings per share basis. 1Life Healthcare employs 1,700 workers across the globe.

The official website for 1Life Healthcare is www.onemedical.com.

1Life Healthcare's mailing address is One Embarcadero Center Suite 1900, San Francisco CA, 94111. The company can be reached via phone at 415-814-0927 or via email at [email protected]